Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...

The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from ...

Neurons in the brains of mice tell them to stop eating when they’ve had enough food – and since people probably have the same ...

"Yo-yo" dieting --- repeatedly losing and gaining weight -- can significantly increase risk of kidney disease among people ...

A pear is a fruit that’s rich in essential antioxidants, plant compounds, and dietary fiber. People consume pears to help with many conditions. Here’s what to know.

The U.S. Food and Drug Administration ordered a hold on a study of an early-stage obesity drug being developed by Amgen, another potential setback in the company’s efforts to join the booming weight ...

Novo Nordisk today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn. Read why I upgrade NVO ...

Losing weight is something that millions of people struggle with, and for many, the solution may lie in medical or surgical ...

Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...

Use of a sodium-glucose cotransporter 2, or SGLT2, inhibitor combined with calorie restriction resulted in greater rates of type 2 diabetes remission compared with calorie restriction alone, according ...

Strength training is key to staying fit after 50. Learn three expert-recommended exercises to build muscle, improve mobility, ...

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...